
OHI Stock Forecast & Price Target
OHI Analyst Ratings
Bulls say
Omega Healthcare Investors Inc. has shown a positive outlook through an increase in its 2025 Funds From Operations (FFO) estimates, rising to $2.81 per share from $2.78, driven by higher investment volume. The company's normalized FFO estimate, excluding non-recurring items, has also been adjusted upward to $2.95 per share from $2.89, indicating stronger financial performance. Additionally, with a year-to-date stock performance of +12%, significantly outpacing the +4% of the VNQ index, Omega Healthcare is currently trading near the higher end of its 10-year valuation range, reinforcing investor confidence in its growth potential.
Bears say
Omega Healthcare Investors Inc. faces a challenging operational environment, leading to skepticism about the company's prospects despite a slight increase in its adjusted funds from operations (FFO) estimate for 2026. The adjusted FFO is projected to rise to $3.22 per share, which, while exceeding the consensus core FFO estimate of $3.10 per share, does not significantly alleviate concerns regarding the company's financial position and relative valuation. Persistent operational difficulties among facility operators further contribute to a negative outlook for the company's stock in the current financial landscape.
This aggregate rating is based on analysts' research of Omega Healthcare Investors and is not a guaranteed prediction by Public.com or investment advice.
OHI Analyst Forecast & Price Prediction
Start investing in OHI
Order type
Buy in
Order amount
Est. shares
0 shares